NSCLClung adenocarcinomaPDACCRCchronic myelomonocytic leukaemia
…dagrasib, evaluated in KRYSTAL-1, showed comparable efficacy in NSCLC (ORR ~43%, PFS 6.5 months, OS 12.6 months) and similarly receiv…
1articles mentioning diseases
1disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: chronic myelomonocytic leukaemia ×
chronic myelomonocytic leukaemia
This disease is selected. Its supporting articles are shown below.